CONCOR-1 Trial

The Convalescent Plasma for COVID-19 Research (CONCOR-1) trial is a collaborative of 🇨🇦 researchers and clinicians, committed to improving COVID-19 care.

[CONCOR-1 Trial @CONCOR1Trial]

New @CanadasLifeline blog post from @JeannieCallum and Research Coordinator Amie Kron - key msg from the @CONCOR1Trial is that #convalescentplasma is not recommended to treat #COVID19 outside of a controlled clinical trial. Read more: https://t.co/LdNFyj5JRq

[CONCOR-1 Trial @CONCOR1Trial]

THANK YOU to all involved in @CONCOR1Trial - patients & family members, plasma donors, research teams, Blood Banks, study investigators, Community Advisory Committee, blood suppliers, & funders. Much knowledge has been gained & further research opportunities borne of this trial.

[CONCOR-1 Trial @CONCOR1Trial]

The @CONCOR1Trial found that #convalescentplasma units with an unfavourable antibody profile (including measures of both antibody quantity and function against SARS-CoV-2) were associated with a higher risk of intubation or death in hospitalized patients with #COVID19

[CONCOR-1 Trial @CONCOR1Trial]

The @CONCOR1Trial found that #convalescentplasma did not reduce the risk of intubation or death in patients hospitalized for #COVID19 compared to patients who received standard of care

[CONCOR-1 Trial @CONCOR1Trial]

Results of the @CONCOR1Trial have been published in @NatureMedicine (https://t.co/Fjqc0P5mib). A summary of the trial findings is available on our website: https://t.co/1tePfAzZg4

[MCTransfusionR @Mac_Transfusion]

On the Plenary Session lineup at the @CanSocTransMed Virtual Conference this morning - @EmilySirotich presenting on engaging #community in clinical trials (with lessons from @CONCOR1Trial)! #CSTM2021SCMT

[CONCOR-1 Trial @CONCOR1Trial]

Thank you to the thousands of individuals involved in @CONCOR1Trial who helped to advance our knowledge during a pandemic: patients and their family members, plasma donors, research teams, blood bank staff, study investigators, blood suppliers, and funders.

[CONCOR-1 Trial @CONCOR1Trial]

On the recommendation of the Data Safety Monitoring Committee, the @CONCOR1Trial has stopped enrolment. Trial update available on our website: https://t.co/1tePfAzZg4

[CONCOR-1 Trial @CONCOR1Trial]

Patients with #COVID19 need your plasma! If you have recovered, please donate today: https://t.co/eDJWTr9jNH

[UBC Centre for Blood Research @CBR_UBC]

#ICYMI: What is #ConvalescentPlasma therapy, and how can it help in the fight against #COVID19?

Dr. Dana Devine (@DrDanaDevine) explains in this video via @GlobalEdmonton: https://t.co/euVYw2RoZe

@CanadasLifeline @CONCOR1Trial @ubclifesciences

[Canadian Blood Services @CanadasLifeline]

"After learning that the antibodies contained in my plasma could help others, I wanted do my little part for a really important cause."

#ThankYou for being a vital link in #CanadasLifeline WATCH: https://t.co/ygIEMlO9yS

[CONCOR-1 Trial @CONCOR1Trial]

Last week, we saw the greatest number of patients enrolled - averaging 10 per day, every day. With this uptick in enrolment comes a growing need for #convalescentplasma! If you have fully recovered from #COVID19, please consider helping others by donating plasma @CanadasLifeline

[Teresa Chan | 陳敏怡 @TChanMD]

Find out more about the @CONCOR1Trial in these nifty infographics.

Or click this link below to find out more:
https://t.co/FTKhQmPsmZ

[CONCOR-1 Trial @CONCOR1Trial]

Plasma could be the key to help others recover from COVID.
If you, or someone you know, have fully recovered from #COVID19, you may be able to help others by donating plasma @CanadasLifeline.
Learn more and register to become a potential donor at https://t.co/VjCZBxLtyS.

[CONCOR-1 Trial @CONCOR1Trial]

@OttawaHospital @CanadasLifeline @OttawaHospital you have been doing a fantastic job with recruitment - thank you for your dedication to @CONCOR1Trial and for helping get the word out about the need for plasma donors!

[CONCOR-1 Trial @CONCOR1Trial]

561 patients randomized! 71 campuses activated! And
@CONCOR1Trial has expanded internationally yet again by adding our first site in Brazil @Hemorio! Thank you to the CONCOR-1 team, patients, and plasma donors that make this research possible.

[CONCOR-1 Trial @CONCOR1Trial]

Canadians who have recovered from COVID-19 are urgently needed to meet the increasing demand for plasma! @JeannieCallum @CanadasLifeline

[Toronto Star @TorontoStar]

With a second wave of COVID-19 in full force, researchers behind a national clinical trial are desperately seeking recovered patients who can donate plasma, and fearing a shortage of the blood product.

New from @maywarren11:
https://t.co/pLP0MEqAOj

[MCTransfusionR @Mac_Transfusion]

14 cities across Canada with a @CanadasLifeline centre accepting #convalescentplasma donations! Donations are urgently needed to support research trials in Canada, including @CONCOR1Trial

[CONCOR-1 Trial @CONCOR1Trial]

100 more patients randomized in 2.5 weeks - sending a big THANK YOU to our amazing trial teams for their dedication and to the #convalescentplasma donors who make this possible! @CanadasLifeline @HemaQuebec @NYBloodCenter

[CONCOR-1 Trial @CONCOR1Trial]

100 patients enrolled in the last 18 days - more than 5 per day! If you have recovered from COVID-19, you could potentially helps others with the virus (including the patients in @CONCOR1Trial) by donating your #ConvalescentPlasma to @CanadasLifeline